Preventing Infections in Sickle Cell Disease: The Unfinished Business

Stephen K Obaro, P. Y Iroh Tam

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

While encapsulated bacterial agents, particularly Streptococcus pneumoniae, are recognized as important microbes that are associated with serious illness in hosts with sickle cell disease (SCD), multiple pathogens are implicated in infectious manifestations of SCD. Variations in clinical practice have been an obstacle to the universal implementation of infection preventive management through active, targeted vaccination of these individuals and routine usage of antibiotic prophylaxis. Paradoxically, in low-income settings, there is evidence that SCD also increases the risk for several other infections that warrant additional infection preventive measures. The infection preventive care among patients with SCD in developed countries does not easily translate to the adoption of these recommendations globally, which must take into account the local epidemiology of infections, available vaccines and population-specific vaccine efficacy, environment, health care behaviors, and cultural beliefs, as these are all factors that play a complex role in the manifestation of SCD and the prevention of infectious disease morbidity.

Original languageEnglish (US)
Pages (from-to)781-785
Number of pages5
JournalPediatric blood & cancer
Volume63
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Sickle Cell Anemia
Infection
Vaccines
Preventive Medicine
Antibiotic Prophylaxis
Streptococcus pneumoniae
Developed Countries
Communicable Diseases
Vaccination
Epidemiology
Morbidity
Delivery of Health Care
Population

Keywords

  • encapsulated bacteria
  • malaria
  • sickle cell
  • vaccination

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Preventing Infections in Sickle Cell Disease : The Unfinished Business. / Obaro, Stephen K; Tam, P. Y Iroh.

In: Pediatric blood & cancer, Vol. 63, No. 5, 01.05.2016, p. 781-785.

Research output: Contribution to journalReview article

@article{775b0295e49c43e88864357dd5e15682,
title = "Preventing Infections in Sickle Cell Disease: The Unfinished Business",
abstract = "While encapsulated bacterial agents, particularly Streptococcus pneumoniae, are recognized as important microbes that are associated with serious illness in hosts with sickle cell disease (SCD), multiple pathogens are implicated in infectious manifestations of SCD. Variations in clinical practice have been an obstacle to the universal implementation of infection preventive management through active, targeted vaccination of these individuals and routine usage of antibiotic prophylaxis. Paradoxically, in low-income settings, there is evidence that SCD also increases the risk for several other infections that warrant additional infection preventive measures. The infection preventive care among patients with SCD in developed countries does not easily translate to the adoption of these recommendations globally, which must take into account the local epidemiology of infections, available vaccines and population-specific vaccine efficacy, environment, health care behaviors, and cultural beliefs, as these are all factors that play a complex role in the manifestation of SCD and the prevention of infectious disease morbidity.",
keywords = "encapsulated bacteria, malaria, sickle cell, vaccination",
author = "Obaro, {Stephen K} and Tam, {P. Y Iroh}",
year = "2016",
month = "5",
day = "1",
doi = "10.1002/pbc.25911",
language = "English (US)",
volume = "63",
pages = "781--785",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Preventing Infections in Sickle Cell Disease

T2 - The Unfinished Business

AU - Obaro, Stephen K

AU - Tam, P. Y Iroh

PY - 2016/5/1

Y1 - 2016/5/1

N2 - While encapsulated bacterial agents, particularly Streptococcus pneumoniae, are recognized as important microbes that are associated with serious illness in hosts with sickle cell disease (SCD), multiple pathogens are implicated in infectious manifestations of SCD. Variations in clinical practice have been an obstacle to the universal implementation of infection preventive management through active, targeted vaccination of these individuals and routine usage of antibiotic prophylaxis. Paradoxically, in low-income settings, there is evidence that SCD also increases the risk for several other infections that warrant additional infection preventive measures. The infection preventive care among patients with SCD in developed countries does not easily translate to the adoption of these recommendations globally, which must take into account the local epidemiology of infections, available vaccines and population-specific vaccine efficacy, environment, health care behaviors, and cultural beliefs, as these are all factors that play a complex role in the manifestation of SCD and the prevention of infectious disease morbidity.

AB - While encapsulated bacterial agents, particularly Streptococcus pneumoniae, are recognized as important microbes that are associated with serious illness in hosts with sickle cell disease (SCD), multiple pathogens are implicated in infectious manifestations of SCD. Variations in clinical practice have been an obstacle to the universal implementation of infection preventive management through active, targeted vaccination of these individuals and routine usage of antibiotic prophylaxis. Paradoxically, in low-income settings, there is evidence that SCD also increases the risk for several other infections that warrant additional infection preventive measures. The infection preventive care among patients with SCD in developed countries does not easily translate to the adoption of these recommendations globally, which must take into account the local epidemiology of infections, available vaccines and population-specific vaccine efficacy, environment, health care behaviors, and cultural beliefs, as these are all factors that play a complex role in the manifestation of SCD and the prevention of infectious disease morbidity.

KW - encapsulated bacteria

KW - malaria

KW - sickle cell

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=84980000592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84980000592&partnerID=8YFLogxK

U2 - 10.1002/pbc.25911

DO - 10.1002/pbc.25911

M3 - Review article

C2 - 26840500

AN - SCOPUS:84980000592

VL - 63

SP - 781

EP - 785

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 5

ER -